Vancouver General Hospital
Vancouver, British Columbia, Canada
NCT Number: NCT04800523
This study aims to determine if a non-functioning UroMonitor device can be safely inserted, monitored, and removed in patients with SCI.
Looking for future studies?
Notify Me17 year–75 year
All sexes
Interventional
Not applicable
Vancouver, British Columbia, Canada
This prospective, observational study will be conducted with 10 patients with chronic thoracolumbar SCI who are already undergoing routine UDS studies as part of their care. Following their routine UDS, a non-functioning UroMonitor device will be inserted and removed after 3 hours. Participants' symptoms will be monitored after the UroMonitor is inserted, following the 3 hour monitoring period, and again after UroMonitor removal. A second cystoscopy will be conducted for research purposes after removal to examine the urethra and bladder for any irritation or trauma. During insertion and removal, the urologist will document the time required for insertion and any difficulties encountered
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantable device to wirelessly and without catheters monitor the neurogenic bladder on an ambulatory basis
Time frame: Day 1 Timepoint: post insertion
11-point numerical visual analogue scale for the participant to document discomfort during the implantation of the UroMonitor.
Time frame: Day 1 Timepoint: post insertion
Study form registers the data on application of the device, such as the time and ease of insertion.
Time frame: Day 1 Timepoint: 1 hr post insertion
Study form used for the purpose of registering data on details of participant symptoms during the 3-hour monitoring period
Time frame: Day 1 Timepoint: post device remove
Study form used for the purpose of recording the condition of the device and patient's experience at the time of sensor removal
Time frame: Day 1 Timepoint: post device remove
Data on details of patient symptoms during device removal is recorded with this form
Time frame: Day 1 Timepoint: post secondary cyctoscopy
This form is used for the purpose of recording the existence of irritation in bladder or urethra after the removal of the device
Looking for future studies?
Notify MeUniversity of British Columbia
Other
The "UroMonitor Trial": Safety, Feasibility, and Tolerability of UroMonitor Insertion in Spinal Cord Injury.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04721717
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07840196
Acute Spinal Cord Injury (SCI), Central Nervous System Diseases
Bayreuth, Germany
View Trial DetailsNCT07128901
Central Nervous System Diseases, Nervous System Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT05244408
Acute Spinal Cord Injury, Acute Spinal Paralysis
Vancouver, British Columbia, Canada
View Trial Details